Edition:
United States

Regenxbio Inc (RGNX.OQ)

RGNX.OQ on NASDAQ Stock Exchange Global Select Market

29.70USD
22 Nov 2017
Change (% chg)

$0.60 (+2.06%)
Prev Close
$29.10
Open
$30.00
Day's High
$30.00
Day's Low
$28.90
Volume
58,941
Avg. Vol
83,865
52-wk High
$35.95
52-wk Low
$16.30

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.34 -0.669
Jun '17 6.56 -0.472
Mar '17 0.46 -0.825
FY 2016 Dec '16 1.70 -0.741
Sep '16 0.12 -0.686
Jun '16 2.38 -0.548
Mar '16 0.39 -0.409
FY 2015 Dec '15 4.44 -0.197
Sep '15 1.14 -0.289
Jun '15 1.36 -0.347
Mar '15 0.64 -0.128
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 3 0.55 1.20 0.00 2.00
Quarter Ending Mar-18 3 1.07 2.00 0.00 2.00
Year Ending Dec-17 4 8.82 15.07 1.80 7.89
Year Ending Dec-18 5 8.50 23.30 0.00 9.17
Earnings (per share)
Quarter Ending Dec-17 4 -0.79 -0.67 -0.92 -0.53
Quarter Ending Mar-18 3 -0.76 -0.69 -0.88 -0.62
Year Ending Dec-17 5 -2.72 -2.43 -2.87 -2.68
Year Ending Dec-18 6 -3.08 -2.73 -3.51 -2.43
LT Growth Rate (%) 1 -7.10 -7.10 -7.10 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 189.94 34.73
P/E High - Last 5 Yrs. -- 286.25 45.10
P/E Low - Last 5 Yrs. -- 95.51 24.21
Beta -- 0.85 0.89
Price to Sales (TTM) 92.05 94.70 5.33
Price to Book (MRQ) 4.75 20.79 5.60
Price to Tangible Book (MRQ) 4.75 24.37 7.13
Price to Cash Flow (TTM) -- 100.38 23.67
% Owned Institutions 69.55 6.10 1.29

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.03
Dividend 5 Year Growth Rate -- 2.03 5.30
Payout Ratio(TTM) -- 104.97 45.36

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 968.80 5.12 6.92
Sales (TTM) vs TTM 1 Yr. Ago 37.02 28.35 5.14
Sales - 5 Yr. Growth Rate -- 33.44 10.37
EPS (MRQ) vs Qtr. 1 Yr. Ago 2.42 -142.83 4.98
EPS (TTM) vs TTM 1 Yr. Ago -47.14 -- --
EPS - 5 Yr. Growth Rate -- 43.56 10.99
Capital Spending - 5 Yr. Growth Rate -- 41.29 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.89 2.54
Current Ratio (MRQ) 12.85 5.54 3.56
LT Debt to Equity (MRQ) 0.00 14.59 12.30
Total Debt to Equity (MRQ) 0.00 16.92 18.25
Interest Coverage (TTM) -- -147.23 43.20

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 75.91 44.52 54.70
Gross Margin - 5 Yr. Avg. -- 55.08 52.19
EBITD Margin (TTM) -770.28 -- --
EBITD - 5 Yr. Avg -- -212.26 15.65
Operating Margin (TTM) -793.67 -524.92 8.15
Operating Margin - 5 Yr. Avg. -- -227.68 11.31
Pre-Tax Margin (TTM) -768.38 -494.06 8.99
Pre-Tax Margin - 5 Yr. Avg. -- -227.56 11.72
Net Profit Margin (TTM) -764.06 -491.57 5.22
Net Profit Margin - 5 Yr. Avg. -- -230.64 8.00
Effective Tax Rate (TTM) -- 15.48 24.19
Effective Tax Rate - 5 Yr. Avg. -- 19.02 24.05

Efficiency

  Company industry sector
Revenue/Employee (TTM) 93,916 22,242,450 866,827,034
Net Income/Employee (TTM) -717,570 -1,532,938 101,086,499
Receivable Turnover (TTM) 12.86 32.92 6.13
Inventory Turnover (TTM) -- 2.68 3.53
Asset Turnover (TTM) 0.05 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -37.89 -8.23 11.40
Return on Assets - 5 Yr. Avg. -- 0.01 12.43
Return on Investment (TTM) -40.68 -10.73 14.56
Return on Investment - 5 Yr. Avg. -- 3.24 16.28
Return on Equity (TTM) -40.96 -36.69 16.06
Return on Equity - 5 Yr. Avg. -- 5.80 17.43
  1 Year 3 Year 5 Year
Sales % -39.52 -8.99 --
EPS (TTM) % -146.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Regenxbio Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -4.50 -5.97 41 77
13 Week 41.09 32.78 87 40
26 Week 57.56 45.87 88 67
52 Week 45.59 23.49 74 47
YTD 60.11 38.02 78 48
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 69.58%
# of Holders: 144
Total Shares Held: 21,669,802
3 Mo. Net Change: -1,577,642
# New Positions: 28
# Closed Positions: 22
# Increased Positions: 79
# Reduced Positions: 50
# Net Buyers: 29
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.